Acute Limb Ischemia (Ali): An Overview Of Clinical Diagnosis And Treatment by Laksono, Gerardo AK et al.
Acute Limb Ischemia (ALI): An …	 	 	 						 	 Laksono GAK, Erwin F, Tahalele PL 
138	
ACUTE LIMB ISCHEMIA (ALI): AN OVERVIEW OF CLINICAL DIAGNOSIS 
AND TREATMENT 
 
Gerardo AK Laksono1), Ferdinand Erwin1), Paul L Tahalele2) 
 
ABSTRACT 
 
 Acute limb ischemia (ALI) is one of vascular emergency. It is defined as a rapid and 
sudden decrease in limb blood flow due to acute occlusion It is considered to be acute if it 
occurs within 14 days after the first symptom onset. The incidence of ALI is around 
1.5/10.000 people per year. It has reported a mortality rate of 15%-20% in 30 days and high 
amputation rates 10%-15% if appropriate treatment not administered. The causes of ALI are 
divided into embolism and thrombosis. Thrombosis can occurred due to atherosclerotic lesion 
while most cases of embolism are cardiogenic one. Classic features of ALI are known as 6Ps: 
pain, pallor, paralysis, paraesthesia, pulselessness, poikilothermia. A good history taking and 
physical examination are needed to assess further treatment needed. Severity of ALI also 
need to be set based on Rutherford Classification. If the limb was diagnosed as irreversible 
damage, amputation should be taken as treatment choice without hesitation. ALI can be 
treated with administered of heparin, endovascular and open surgical. Post treatment follow 
up also needed to rule out any possible complication such as compartment syndrome and 
ischemic-reperfusion injury.  
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INTRODUCTION  
 Acute limb ischemia (ALI) defined 
as a rapid and sudden decrease in limb 
blood flow due to acute occlusion and 
represented as a vascular emergency1. It is 
considered to be acute if it occurs within 14 
days after the first symptom onset. Different 
from chronic limb ischemia in which 
collateral vascularization often present, ALI 
threatens limb in a short time. The rapid 
ischemia period affects all tissue of the 
limb, such as skin, tissue, and nerve2. It can 
result in amputation unless appropriate 
management is administered. Thus, 
emergency treatment with revascularization 
is needed to preserve limb viability. Acute 
upper limb ischemia (AULI) is different 
from lower limb ischemia. AULI is less 
common than lower ischemia. In clinical 
appearance, the shoulder and elbow part 
much more tolerant of ischemia due to well 
collateral development, therefore it is more 
common to serve in below-elbow which 
brachial artery is the most common side of 
occlusion1,3.  
The incidence of ALI is around 
1.5/10.000 people per year. It has reported a 
mortality rate of 15%-20% in 30 days and 
amputation rates 10%-15%4,5. A study by 
Baril et al. also showed that ALI patients 
experience increased in-hospital major 
adverse events, including myocardial 
infarction, congestive heart failure, renal 
failure, and respiratory complications6. 
ETIOLOGY 
 Several different factors can cause 
ALI. The causes of ALI, excluding trauma, 
are divided into embolism and thrombosis. 
Arterial thrombosis due to plaque 
complication (40%) has the highest number 
followed by an arterial embolism (30%), 
thrombosis of a popliteal aneurysm (5%), 
trauma (5), or graft thrombosis (20%)7,8. 
Another study by Belle et al. showed that 
arterial embolism (46%) has the highest 
number that can cause ALI followed by in 
situ thrombosis (24%), complex factor 
(20%), and stent- or graft related thrombosis 
(10%)9. In 2012 annual report of the 
Japanese Society for Vascular Surgery 
based on data from the National Clinical 
Database showed that patients with 
embolism and thrombosis are half of the 
total patients on the database10.  
Potential embolic that caused an 
acute decrease in limb perfusion is 
cardiogenic embolism; the majority arises 
from left atrial appendage associated with 
atrial fibrillation (80%)11. These emboli 
form due to poor cardiac wall motion 
leading to stagnant blood in cardiac 
chambers and clot formation. Other emboli 
can be caused by post valve replacement, 
left ventricle wall thrombosis following 
myocardial infarction, cardiac/aortic tumor, 
and embolus carried from venous side of 
circulation to the arterial side called as 
paradoxical embolism12. Shaggy aorta 
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syndrome13 that can cause spontaneous 
atheromatous visceral embolization from 
diffuse aortic atherosclerotic disease can be 
caused by ALI as well as aneurysm 
associated with mural thrombus and 
iatrogenic embolism by catheter 
manipulation. Intraarterial drug 
administration can cause ALI by intense 
spasm and microvascular thrombosis14. 
Peripheral embolism caused by popliteal 
artery aneurysm and thrombotic occlusion 
from a true aneurysm is not rare and needs 
more caution. Some conditions such as 
intracardiac masses (myxoma, vegetation), 
calcified debris post transcatheter aortic 
valve implantation (TAVI), dissection of 
pelvic and lower extremity arteries are 
essential to be identified because of 
different treatment. The most common side 
of embolism is the femoral artery15.  
Thrombotic limb ischemia occurs in 
patients with underlying peripheral artery 
disease (PAD). Chronic stenotic lesions in 
occlusive atherosclerosis cause acute 
obstruction resulting from plaque 
breakdown, circulatory failure, or a 
hypercoagulable state. It can be caused by 
occlusion of stents and bypass graft. 
Thrombosis in situ may arise from acute 
plaque rupture, hypovolemia, or pump 
failure. Usually, limbs that have stable 
chronic ischemia do not suddenly worsen 
without any reason16. It is often challenging 
to distinguish embolism from thrombosis. 
Trauma can occur because of non-iatrogenic 
ALI. The commonest are limb fractures and 
dislocations, blunt injury and stab wounds. 
Trauma can lead to vascular injury that 
results in vascular damage. Compartment 
syndrome results from trauma that can be 
caused by compression inside the vascular 
compartment lead to ALI17–19. Some 
orthopedic procedures on the limb, 
especially with a tourniquet and pelvic 
surgery in a patient with the aortoiliac 
disease in which pelvic collaterals are 
ligated, form the main blood supply to the 
legs. Lower limb ischemia needs further 
assessment if there is the presence of 
epidural or spinal anesthesia. Hugl et al. 
reported a case of upper acute limb ischemia 
caused by thoracic outlet syndrome (TOS). 
TOS caused by compression or irritation of 
the neurovascular bundle at the level of the 
costoclavicular passage is an unusual case 
of ALI. Upper extremity ischemia caused by 
TOS is less than 5% of patients20,21. 
 
PATHOLOGY 
 The longer time the limb without 
oxygen, the greater chance it becomes 
irreversible. The ischemia starts from the 
most sensitive part, which is nerve, skin, 
and subcutaneous tissue to skeletal muscle. 
Ischemia causes a decrease in oxygen level 
in tissues, leading to the inability of 
mitochondrial oxidative phosphorylation. In 
ischemia, the condition occurs obstruction 
Online-ISSN 2565-1409                     Journal of Widya Medika Junior Vol. 2 No. 2 April 2020 
141	
of blood vessels causes dysfunction in the 
electron transport chain22,23. Lack of ATP 
production that leads to anaerobic 
metabolism, which produces a low level of 
pH in the cell. In ischemia condition, 
Sodium-dependent pH regulatory including 
Na+/H+ exchanger and Na+ - HCO3 
transporter are activated. Hydrogen ions are 
excreted by Na+/H+ exchanger, which 
produces a large influx of sodium to balance 
the accumulation of hydrogen ions due to 
the decrease of pH In ischemia conditions. 
Cellular ATP depleted, which Inactivates 
ATPases leads to ultrastructural damage to 
mitochondria4,24.  
Ischemia tissue produces oxygen-
free radicals. Peroxidation of membrane 
lipids, increase in capillary permeability and 
swelling can be caused by oxygen free 
radicals. Inflammation and leukocyte-
activated platelets in ischemia conditions 
cause activation of the complement system 
and platelet aggregation. This results in the 
no-reflow phenomenon lead to the release 
of cell death into the systemic circulation. 
Prolonged ischemia can caused a condition 
such as myonephropatic metabolic 
syndromes. MNMS is a condition where 
muscle cell is liquefactive necrosis and 
accumulation of K+ ion, myoglobin creatine, 
lactic acid and superoxide occur in affected 
limb. This condition can cause sudden death 
from heart failure and renal failure22,25. 
  
4. DIAGNOSIS 
4.1 Signs and Symptoms 
 Symptoms of ALI usually develop in 
several minutes, to hours or day. In total 
arterial obstruction, irreversible change in 
nerves happened in 4-6 hours, muscles in 6-
8 hours, and skin in 8-12 hours. It starts 
with intermittent claudication end develop 
until it becomes severe rest pain, 
paraesthesia, muscle weakness, paralysis, 
and gangrene. Clinical features of ALI are 
mnemonic known as the Six Ps: pain, pallor, 
paralysis, paraesthesia, pulselessness, 
poikilothermia3,26. Pain is usually the first 
symptom of ALI, start from the distal part 
of the limb and gradually progressing 
proximally with increased duration of 
ischemia. After ischemia progress to the 
neurological damage stage, the pain may 
begin to diminish. Numbness is a common 
complaint associated with persistent limb 
ischemia. As ischemia progresses, 
anesthesia and paralysis become more 
prominent27. 
A good history taking and physical 
diagnosis are very important to ALI for 
further management. It is often difficult to 
distinguish between embolic or thrombotic, 
and clinically possible only in around 15% 
ALI cases. In general, sudden onset 
development of ischemia symptoms in a 
patient with previously asymptomatic is 
most consistent with an embolus, and 
sudden worsening symptoms in a patient 
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with a history of chronic ischemia and 
claudication is more indicative of 
thrombosis.  Patient with thrombosis usually 
has significant comorbidities such as 
coronary artery disease, stroke, diabetes, 
and renal failure. At the same time, the prior 
history of embolism, arrhythmia suggesting 
atrial fibrillation, aneurysm are 
comorbidities for embolic. Unclear onset 
and confusing complaints can be caused by 
atherosclerotic plaque. Collateral vessels to 
the distal regions of limb usually occur with 
gradual progression of atherosclerosis. 
Vascular spasm and marble white of limb 
appear on acute arterial occlusion. After the 
vessel relax, the deoxygenated blood will 
fill the skin leading to mottled that blanches 
on pressure (Table 1)11 
 
Table 1. The Difference between Embolism and Thrombosis11 
 
The severity of ALI is classified 
using the Rutherford classifications. 
Classification of severity is important  
 
 
 
 
because the evaluation and treatment 
of ALI are based on the degree of tissue 
ischemia and limb prognosis (Table 2)27,28 
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Figure 1. Clinical condition of Acute Lower Limb Ischemia and Upper Limb Ischemia 
(Tahalele & Gerardo's documentation and Fauzan's documentation28)
 
 
Table 2. Acute Limb Ischemic (ALI) Severity Based on Rutherford Classification11 
 
4.2 Imaging 
 Duplex ultrasound (DUS) is the first 
imaging choice to assess ALI because it is 
widely available, low cost, non-invasive, 
non-irradiant procedure, and it takes a 
relative time to perform. DUS shows 
important information like anatomic 
location, degree of obstruction (complete or  
incomplete), hemodynamics (proximal and 
distal to the obstruction), and is highly 
useful for the follow up of revascularization 
treatment29. DUS imaging uses 2D 
ultrasound, a color Doppler, and a pulsed 
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wave Doppler. This procedure provides 
excellent data at femoral and popliteal 
levels, while aortic and iliac arteries may be 
difficult to evaluate, especially in obese 
patients or gas interposition2. A non-
pulsatile artery, without color flow, with a 
thrombus within the lumen, indicated the 
site of arterial occlusion. DUS can also 
differentiate between a thrombosis on a 
preexisting chronic and severe stenosis and 
an embolic event. Venous examination 
using DUS may also be useful for the 
differential diagnosis and appropriate 
staging of ALI30. 
Computed Tomography 
Angiography (CTA) and Magnetic 
Resonance Angiography (MRA) is high-
resolution imaging tools and usually used to 
confirm the diagnosis and demonstrate the 
location and extent of arterial occlusion. 
The ability to visualize calcification, stents, 
and bypasses is the most significant 
advantage of CTA. Contrast agents can 
worsen renal failure and contraindicated in 
patients with a glomerular filtration rate 
(GFR) lower than 60 mL/min30. 
Gadolinium-enhanced MRA has excellent 
sensitivity (93–100%) and specificity (93–
100%) compare to digital subtraction 
angiography (DSA) for assessing peripheral 
arterial disease4,5. MRA is useful in patients 
with allergies or moderate renal failure but 
contraindicated in patients with severe renal 
failure (GFR below 30 mL/min) and the 
presence of pacemakers or metal implants. 
CTA and MRA are reserved for patients 
with a non-immediately threatened limb 
because of long imaging sessions30. 
 
 
Figure 2 (a) Absent color flow at superficial 
femoral artery (SFA) because of intraluminal 
thrombosis (black arrow) with normal color 
filling of the SFA (white arrow) and noted 
collaterals beside the SFA (arrowhead). (b) Distal 
SFA monophasic low velocity flow Doppler 
(arrow). (c) Left SFA thrombosis showing absent 
opacification with distal collateral refilling (white 
arrows). Right SFA stenotic segments (blue 
arrows) computed tomography angiography15,31 
 
DSA is an invasive angiogram 
procedure and was considered as the “gold 
standard” for ALI diagnosis. This procedure 
is useful to distinguish an embolic occlusion 
from in situ thrombosis and shows the site 
of occlusion and distal arterial tree. 
However, because it is an invasive 
procedure so there is a potential risk of 
complications, DSA should not be used as a 
first diagnostic method and should not 
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replace DUS for positive diagnosis of ALI. 
DSA is complementary to DUS and plays 
an essential role in the theurapeutic 
strategy30 
 
4. Treatment 
 All patients with ALI, an 
intravenous injection of unfractioned 
heparin (50-100 units/kg) is immediately 
administered to prevent further clot 
propagation and allows time for assesment 
of adequancy of collateral flow and 
preparation for operation, as long as heparin 
therapy is no contraindicated32. For patients 
with viable or a marginally threatened limb 
(Rutherford class I and IIa), it is indicated to 
perform imaging (duplex ultrasonography, 
computed tomographic angiography, or 
magnetic resonance angiography) and 
endovascular revascularization is the 
appropriate initial treatment. In severly 
threatened limb (Rutherford class IIb), 
immediate revascularization is required 
within 3 to 6 hours for limb salvage and 
may best be served with surgical 
intervention. Class IIb patients should be 
examined by imaging where it is rapidly 
availble to guide management and aid 
prompt revascularization30. Amputation is 
appropriate in patients with irreversible limb 
(Rutherford class III) without attempt at 
vascular revascularization, as it is may 
expose the patient to the serious hazards of 
reperfusion caused by release of acidic and 
hyperkalemic venous blood from dying 
tissue26. Intaoperative angiography may be 
performed after revascularization procedure 
to detect pre-existing arterial lessions or 
outflow obstruction30.  
 
Figure 3 Algorithm for the treatment of 
acute limb ischemia  
Endovascular treatment includes 
catheter-directed thrombolysis (CDT), 
percutaneous thromboaspiration (PAT), 
with or without thrombolytic therapy, or 
percutaneous mechanical thrombectomy 
(PMT), to restore blood as quickly as 
possible to the threatened limb, with the use 
of drugs, mechanical devices, or both. 
Generally, CDT is not indicated in class IIb 
patients because of a long time to 
reperfusion. CDT is often indicated for ALI, 
which affects the femoral artery and arteries 
distal to the femoropopliteal arteries. 
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Thrombolytic agents are injected within the 
thrombus by inserting 6-F sheath guidewire 
anterogradely in the common femoral artery 
of the affected side, then followed by a 4-F 
multihole catheter positioned in the 
thrombus15. Thrombolytic agents degrade 
fibrin by converting plasminogen to 
plasmin33. The main thrombolytic agents 
that are currently used for ALI are alteplase, 
urokinase, and streptokinase. During 
infusion of thrombolytic agents, patients 
should be admitted to an intensive care unit, 
blood count, and coagulation profile are 
mandatory to be periodically measured. 
Patients should not undergo CDT if 
suspected graft infection, symptom duration 
> 14 days, contraindication for thrombolysis 
(listed in Table 3), and failure to position 
the catheter across the thrombus 
Tabel 3 Contraindicaitons to thrombolytic therapy (adapted from Schwartz) 
Absolute contraindications 
Established cerebrovascular events (including transient ischemia attack) within the 
last two months 
Active bleeding diathesis 
Recent (<10 days) gastrointestinal bleeding 
Neurosurgery (intracranial or spinal) within the last three months 
Intracranial trauma within the last three months 
Intracranial malignancy or metastasis 
Relative contraindications 
Cardiopulmonary resuscitation within the last ten days 
Major nonvascular surgery or trauma within the last ten days 
Uncontrolled hypertension (>180 mmHg systolic or >110 mmHg diastolic) 
Puncture of noncompressible vessel 
Intracranial tumor 
Recent eye surgery 
Minor contraindications 
Hepatic failure, particularly with coagulopathy 
Bacterial endocarditis 
Pregnancy 
Diabetic hemorrhagic retinopathy 
 
PAT and PMT may extend the applicability 
of endovascular treatment to patients with 
more advanced degrees of ALI (class IIb) 
and contraindicate to thrombolysis32. PAT 
provides a low-cost and rapid technique that 
uses large lumen catheters (6–8F) connected 
to a syringe. Furthermore, it is highly 
effective for acute iatrogenic distal 
embolization during an endovascular 
procedure. The concurrent use of CDT with 
PAT is recommended and is expected to 
shorten the duration of ischemia more 
compared with that by CDT alone, with the 
primary success rate reached 90%o30,32. 
PMT is defined as endovascular thrombus 
maceration and removal using percutaneous 
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thrombectomy devices and mainly indicated 
in class IIb patients because the time to 
reperfusion is significantly shorter than 
CDT. PMT may also be used as an 
adjunctive procedure for CDT that followed 
by incomplete thrombolysis or to treat distal 
embolic complications30. Conjunction with 
thrombolytic agents enhance clot lysis and 
limit the doses and time required for 
thrombolysis15. In one study by Blaisdell F., 
the amputation-free survival at 12 months 
was better in PMT compared to CDT or 
surgical thrombectomy34. 
The surgical approach of ALI 
includes thromboembolectomy with a 
balloon catheter (Fogarty), bypass surgery, 
and other adjuncts such as endarterectomy, 
patch angioplasty, and intra-operative 
thrombolysis. A combination of these 
techniques is frequently required. Surgical 
revascularization is preferred in a patient 
with an immediately threatened limb, 
suspected infection bypass graft, occlusion 
symptoms have been present for more than 
two weeks, or contraindication to 
thrombolysis35. Fogarty catheter for 
thromboembolectomy developed by 
Thomas Fogarty in 1963, it changed the 
treatment for ALI and largely improved the 
associated treatment results32,34. In surgical 
intervention, the groin is opened through a 
vertical incision, exposing the common 
femoral artery and its bifurcation. The 
location of the embolus at the femoral 
bifurcation can be detected by distally 
disappeared of the proximal femoral pulse. 
The artery is clamped and opened 
transversely over the bifurcation. The 
thrombus is extracted by passing a Fogarty 
balloon embolectomy catheter. The 
procedure is repeated until back-bleeding, 
and antegrade bleeding occurs, which 
suggests that the entire clot has been 
removed30. A recent refinement treatment is 
the use of the over-the-wire type Fogarty 
catheter. This procedure enabling 
intraoperative selective fluoroscopically 
assisted thromboembolectomy into distal 
vessels30,32. Additional endovascular 
treatments are performed (hybrid treatment) 
when sufficient peripheral blood flow 
cannot be obtained despite 
thromboembolectomy. If there are good 
distal vessels, and the saphenous vein is 
suitable, the surgical bypass is 
recommended because it is fast, durable, 
and reliable. In the absence of a good distal 
target and saphenous vein, or a patient at 
high risk for surgery, thrombolysis is 
recommended35. Patch angioplasty should 
be considered to avoid the narrowing of the 
artery36. 
One meta-analysis of five 
randomized trials with a total of 1283 
participants was included comparing 
catheter-directed thrombolytic therapy with 
surgery for acute limb ischemia showed 
similar rates of limb salvage and mortality 
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rates. Still, thrombolysis was associated 
with higher rates of stroke, major 
hemorrhage, and distal embolization within 
30 days37. Based on these trials and more 
recent case series, catheter-directed 
thrombolysis has the best results in patients 
with a viable or marginally threatened limb, 
recent occlusion (no more than two weeks’ 
duration), thrombosis of a synthetic graft or 
an occluded stent, and at least one 
identifiable distal runoff vessel. Surgical 
revascularization is generally preferred for 
patients with an immediately threatened 
limb or with symptoms of occlusion for 
more than two weeks. 
Successful revascularization 
manifested by relief of pain, restoration of a 
palpable foot pulse, audible arterial Doppler 
signals, and visible improvement of foot 
perfusion (e.g., capillary refill, increased 
temperature, and sweat production)37,38. 
Once revascularization successful, a 
reperfusion injury may develop with 
significant swelling requiring surgical 
fasciotomy to treat the compartment 
syndrome that may accompany the 
reperfusion injury to prevent irreversible 
neurologic and soft-tissue damage. Peroneal 
nerve dysfunction may occur due to 
compression of the anterior compartment of 
the leg because it is the most susceptible to 
this phenomenon. Renal insufficiency from 
myoglobin release should be anticipated 
after the reperfusion of ischemia muscle. 
Treatment consists of aggressive hydration 
and alkalinization of the urine. 
Oral anticoagulant with 
unfractionated heparin is continued after 
thrombolysis, or surgical hemostasis has 
been ensured. For thrombosis and 
cardiogenic embolism associated with the 
thrombophilic conditions and localized 
lesions, long-term anticoagulant therapy 
with warfarin is needed to decrease the 
recurrence rate39.  All patients with a history 
of ALI need long-term follow-up with a 
cardiovascular specialist. In those with 
identified peripheral arterial disease, 
appropriate secondary preventive measures 
such as daily exercise, smoking cessation, 
diabetic control, blood pressure and 
treatment of hyperlipidemia should be 
instituted39. 
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